[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350601-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350601-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ultrasound-responsive-nanodroplets-activate-the-hippo-pathway-via-ros-mst1-yap-cascade-for-breast-cancer-therapy-research-article","Ultrasound-responsive nanodroplets activate the Hippo pathway via ROS-MST1-YAP cascade for breast cancer therapy - Research Article","","Dysregulated Hippo signaling drives malignant proliferation, invasion, and distant metastasis, while precise modulation of this pathway remains a clinical challenge. This study reports albumin-based ultrasound-responsive nanodroplets (FLU-NDs) encapsulating fluvastatin to reprogram Hippo signaling for efficient tumor suppression. FLU-NDs show strong drug loading, biocompatibility, and contrast-enhanced ultrasound performance. UTMD combined with FLU-NDs synergistically regulates the ROS–MST1–YAP axis, inducing apoptosis, reversing EMT, and inhibiting tumor growth and metastasis in vitro and in vivo, providing a low-toxicity theranostic platform.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ultrasound-responsive-nanodroplets-activate-the-hippo-pathway-via-ros-mst1-yap-cascade-for-breast-cancer-therapy-research-article/350601/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ultrasound-responsive-nanodroplets-activate-the-hippo-pathway-via-ros-mst1-yap-cascade-for-breast-cancer-therapy-research-article/350601.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What therapeutic problem does this study address in triple-negative breast cancer?","Question",{"text":63,"@type":64},"Triple-negative breast cancer lacks hormone receptors and HER2, leading to aggressive behavior, limited benefit from existing targeted therapies, and frequent early distant metastasis. Chemotherapy toxicity and chemoresistance further worsen outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do ultrasound-responsive nanodroplets (FLU-NDs) work in this approach?",{"text":68,"@type":64},"Albumin-based FLU-NDs are delivered and accumulate in tumors via albumin-mediated enrichment. Ultrasound-triggered microbubble destruction enables spatiotemporally precise FLU release.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does the ROS–MST1–YAP regulatory axis play?",{"text":72,"@type":64},"Cavitation-induced ROS activates upstream kinase MST1, while ultrasound-triggered FLU release suppresses downstream YAP. Together, this coordinated upstream activation and downstream inhibition modulates the Hippo pathway for tumor suppression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350601,1790126688,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Ultrasonics Sonochemistry 131 (2026) 107949  \nContents lists available at ScienceDirect  \nUltrasonics Sonochemistry  \njournal [homepage:](homepage: www.elsevier.com/locate/ultson)[ www.elsevier.com/locate/ultson](homepage: www.elsevier.com/locate/ultson)  \n| Ultrasound-responsive nanodroplets activate the Hippo pathway via ROS-MST1-YAP cascade for breast cancer therapy\u003Cbr>Yuye Fu a,1, Yading Zhao a,1, Lu Guo a, Dandan Shia, Xiao Sun a, Mengmeng Shang a, Xiaoxuan Wang a, Rui Liu a, Shuting Huang a, Xiaoyue Zhang a, Jie Lia,b,* \u003Cbr>a Department of Ultrasound, Qilu Hospital of Shandong University, No. 107, West Wenhua Road, Lixia district, Jinan, Shandong 250012, China b Department of Ultrasound, Qilu Hospital (Qingdao) of Shandong University, No. 758, Hefei Road, Shibei district, Qingdao, Shandong 266035, China |  |\n| --- | --- |\n| A R T I C L E I N F O\u003Cbr>Keywords:\u003Cbr>Hippo\u003Cbr>Nanodroplet\u003Cbr>Ultrasound-targeted microbubble destruction Reactive oxygen species\u003Cbr>YAP\u003Cbr>Triple-negative breast cancer | A B S T R A C T\u003Cbr>Dysregulated Hippo signaling critically promotes malignant proliferation, invasion and distant metastasis across multiple cancers, while precise and coordinated modulation of this core pathway remains a major unmet therapeutic hurdle in clinical cancer treatment. Here, we report for the first time the albumin-based, ultrasoundresponsive nanodroplets (FLU-NDs) encapsulating fluvastatin (FLU) to achieve accurate and targeted Hippo pathway reprogramming for efficient tumor suppression. FLU-NDs possess satisfactory drug-loading capability, excellent biocompatibility, and robust contrast-enhanced ultrasound performance. Notably, FLU-NDs achieve efficient tumor accumulation through a dual-delivery strategy that integrates albumin-mediated enrichment with ultrasound-triggered spatiotemporal precise release. Mechanistically, we provide evidence for the first time that ultrasound-targeted microbubble destruction (UTMD) combined with FLU-NDs enables synergistic modulation of Hippo pathway through a reactive oxygen species (ROS)-mammalian sterile 20-like kinase 1 (MST1)-yes-associated protein (YAP) regulatory axis. Specifically, cavitation-induced ROS effectively activates upstream kinase MST1, while ultrasound-triggered release of FLU suppresses the downstream YAP, thereby facilitating coordinated upstream activation and downstream inhibition. Using this previously unrecognized UTMD-associated Hippo modulation strategy, FLU-NDs induce robust apoptosis, reverse EMT, and significantly inhibit tumor growth and metastasis in vitro and in vivo. Collectively, this study establishes a novel, high-efficacy and lowtoxicity theranostic platform for precise Hippo-targeted cancer therapy. |\n\n1. Introduction  \nThe absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression in triple-negative breast cancer (TNBC) contributes to its aggressive clinical behavior, making it the most formidable subtype[1]. No benefit is derived from endocrine treatment or HER2-targeted agents in patients with TNBC. Asa result, patients with TNBC often develop early distant metastases. Systemic chemotherapy continues to be a main clinical approach; however, it is associated with substantial toxicity and frequently leads to the development of chemoresistance, ultimately contributing to poor patient outcomes[2]. In this context, the development of innovative therapeutic strategies capable of overcoming drug resistance and efficiently inhibiting tumor progression and metastasis is urgently required  \nto improve the clinical outcomes of TNBC patients.  \nEvidence suggests that the Hippo pathway serves as a key intrinsic safeguard against tumor progression, while also playing a crucial role in the regulation of epithelial–mesenchymal transition (EMT)[3–5]. Dysregulation of Hippo signaling contributes to proliferation and metastasis across multiple cancers[6,7]. The pathway comprises the mammalian sterile 20-li","cbCaipanrZgbZX72","https://ap.wps.com/l/cbCaipanrZgbZX72","pdf",35340558,17,"English","# Introduction\n## Background of triple-negative breast cancer (TNBC)\n## Role of Hippo signaling and YAP/TAZ in TNBC\n## Fluvastatin (FLU) rationale and limitations\n## Study strategy and mechanistic concept","[{\"question\":\"What therapeutic problem does this study address in triple-negative breast cancer?\",\"answer\":\"Triple-negative breast cancer lacks hormone receptors and HER2, leading to aggressive behavior, limited benefit from existing targeted therapies, and frequent early distant metastasis. Chemotherapy toxicity and chemoresistance further worsen outcomes.\"},{\"question\":\"How do ultrasound-responsive nanodroplets (FLU-NDs) work in this approach?\",\"answer\":\"Albumin-based FLU-NDs are delivered and accumulate in tumors via albumin-mediated enrichment. Ultrasound-triggered microbubble destruction enables spatiotemporally precise FLU release.\"},{\"question\":\"What role does the ROS–MST1–YAP regulatory axis play?\",\"answer\":\"Cavitation-induced ROS activates upstream kinase MST1, while ultrasound-triggered FLU release suppresses downstream YAP. Together, this coordinated upstream activation and downstream inhibition modulates the Hippo pathway for tumor suppression.\"}]","Ultrasound-responsive nanodroplets activate the Hippo pathway via ROS-MST1-YAP cascade for breast cancer therapy - Research Article | PDF",1790089841,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e91a08b94592af83ce48078b3b297388.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4adf5f449ddfefcfcf3c9a71545c84ea.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0af4b5df69f62832aeadcf8956e3bc7b.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c216bff779af881e7512c0a163c8e55.webp",980,1306]